Personalized Neoantigen Vaccine and Pembrolizumab for Advanced Hepatocellular Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial
Nat. Med. 2024 Apr 07;[EPub Ahead of Print], M Yarchoan, EJ Gane, TU Marron, R Perales-Linares, J Yan, N Cooch, DH Shu, EJ Fertig, LT Kagohara, G Bartha, J Northcott, J Lyle, S Rochestie, J Peters, JT Connor, EM Jaffee, I Csiki, DB Weiner, A Perales-Puchalt, NY SardesaiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.